Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications
Hamed Helisaz, Data Scientist, Co-Founder of GranTAZ, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in JTH, adding:
“Our recent publication has been featured by NEJM Group
We utilize Machine Learning to show that missing heart medications just one day a week poses a much higher risk than previously thought. Global guidelines traditionally considered an 80% adherence rate ‘good enough’ but our advanced computer modeling proved that patients actually need 90% to 95% adherence to safely minimize the risk of stroke.”
1 Title: Optimal adherence thresholds for oral anticoagulants in patients with atrial fibrillation using machine learning and population administrative data
Authors: Abdollah Safari , Hamed Helisaz , Mina Tadrous , Marc W Deyell , Jason G Andrade , Shahrzad Salmasi , Adenike Adelakun , Kristian B Filion , Mary A De Vera , Peter Loewen
Read the Full Article on JTH.

2 Title: Defining Optimal Adherence to Oral Anticoagulants in Patients with Atrial Fibrillation
Authors: Paul S. Mueller
Read the Full Article on NEJM.

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 26, 2026, 15:04Sequential Efgartigimod and Eltrombopag Achieve Durable Response in Refractory ITP – Platelets Journal
-
Aug 26, 2026, 14:46Holly O’Byrne: A Framework for Developing and Managing Prehospital Blood Programs
-
Aug 26, 2026, 14:32Eleftherios Mylonakis: Earlier Intervention, Better Risk Stratification, Stronger BP Control
-
Aug 26, 2026, 14:32Bringing ISTH 2026 Research to the Global Scientific Community
-
Aug 26, 2026, 14:18Thomas Dayspring: Prognostic Impact of Lp(a) Changes Following Statin Therapy in Patients with CAD
-
Aug 26, 2026, 14:17Khurram Nasir: Are We Debating the Wrong Thing About Research in Medical Training?
-
Aug 26, 2026, 14:15Nathan Connell: Why Format Free Publishing Still Demands Formatting?
-
Aug 26, 2026, 14:14Reza Shojaei: China’s Reliance on Imported Albumin Raises Global Plasma Security Concerns
-
Aug 26, 2026, 14:03Ahmad Masri: The Amyloid Depleter Revolution in ATTR-CM